Mucofalk® D, Pflanzliches Quellmittel Zur Stuhlregulierung (Ispaghula Husk)

Ispaghula Husk, the active ingredient in Mucofalk® D, is a bulk-forming laxative presented as an oral powder for oral use. It is used to relieve occasional constipation and to help regulate stool consistency in adults and children.

GNH USA supplies Mucofalk® D as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide. The company adheres to EU quality standards and provides regulatory support for global distribution.

Mucofalk® D, a bulk‑forming laxative, is indicated for conditions affecting bowel regularity.

- Constipation: facilitates softer, bulkier stools and promotes regular bowel movements. - Stool regulation: helps maintain consistent stool form and frequency. - Functional bowel disorders with constipation: supports symptom relief by normalising transit.

Like other bulk‑forming agents, Mucofalk® D may be associated with a range of adverse reactions.

Common Side Effects: - Abdominal bloating - Flatulence - Mild abdominal cramps - Increased stool frequency - Soft stools - Nausea

Serious or Rare Side Effects: - Intestinal obstruction - Severe abdominal pain - Allergic reactions such as rash or swelling - Rectal bleeding (rare)

When using Mucofalk® D, consider the following precautions to minimise risk.

- Dose adjustment: consider a lower dose in patients with limited fluid intake. - Hydration: ensure adequate water consumption to prevent intestinal blockage. - Medical conditions: use with caution in patients with bowel strictures, severe constipation, or gastrointestinal obstruction. - Medication timing: avoid taking simultaneously with other oral medications that may be delayed by increased viscosity. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep container tightly closed, protect from moisture and direct sunlight.

Mucofalk® D can affect the absorption of certain medicines; review the following interactions.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide) may reduce the laxative effect. - Mineral supplements such as iron or calcium can bind the fiber and diminish its efficacy. - Certain antibiotics (e.g., tetracycline) may have delayed absorption when taken together.

Moderate Interactions (Monitor Closely): - Oral diabetes medications (e.g., metformin) may have altered absorption. - Thyroid hormone replacement (levothyroxine) may experience reduced uptake. - Anticoagulants (e.g., warfarin) may show variable effect due to changes in gut flora.